Clinical Trial: A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277660) titled 'A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis' on Dec. 02.

Brief Summary: The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: BIOLOGICAL: Galvokimig

Drug: Galvokimig Pharmaceutical form: Solution for injection

DRUG: Placebo

Drug: Placebo Pharmaceutical form: Solution for injection

Recruitmen...